Intermittent clearance of p21-highly-expressing cells extends lifespan and confers sustained benefits to health and physical function
Authors:
- 6 August 2024
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 36 (8) , 1795-1805.e6
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG044271, P01AG062413, R33AG061456, P30CA034196, R37AG013925, P30AG068635, AG071292, P30AG013319, P30AG067988)
- Noaber Foundation
- American Foundation for Aging Research
- Glenn Foundation for Medical Research
- University of Connecticut
- Mayo Clinic
- National Institute on Aging (AG066679, AG072374, AG068860, AG076642)
This publication has 27 references indexed in Scilit:
- Cellular Senescence as a Targetable Risk Factor for Cardiovascular DiseasesJACC: Basic To Translational Science, 2024
- Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeletonNature Communications, 2023
- The heterogeneity of cellular senescence: insights at the single-cell levelTrends in Cell Biology, 2022
- Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesityCell Metabolism, 2021
- Longevity leap: mind the healthspan gapnpj Regenerative Medicine, 2021
- From discoveries in ageing research to therapeutics for healthy ageingNature, 2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespanNature, 2016
- Proinflammatory Cytokines, Aging, and Age-Related DiseasesJournal of the American Medical Directors Association, 2013
- The Hallmarks of AgingCell, 2013